Vertex Pharmaceuticals Incorporated (VRTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Vertex Pharmaceuticals Incorporated, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$529.69
+1.66% today
Market cap
$132.1B
Overall quality
—
Kronos AI 30-day
−6.4%
0 of 8 simulated paths end higher
Vertex Pharmaceuticals Incorporated (VRTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $132.1B. It trades at $529.69, up 1.66% today. 25 analysts' average target of $589.50 implies +11.3% from today's price. Kronos AI's 30-day forecast is −6.4% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $589.50 |
| Low – high | $442.00 – $667.00 |
| Analysts | 25 |
| Upside to average | +11.3% |
Kronos AI 30-day forecast
| Expected close | $487.74 (−6.4%) |
| Likely range | −15.4% … −2.9% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.